The inaugural International Cannabinoid-Based Drug Discovery and Development Congress will welcome researchers and industry leaders in medicinal cannabis and pharma to explore an array of drug targets, therapies, manufacturing processes, international regulatory frameworks, clinical studies and market opportunities for cannabinoid-based pharmaceuticals.

Making Pharmaceuticals 2020 has opened a new CBD zone within the exhibition and conference, aimed at promoting and supporting the excellent work that is being carried out in this sector.

The new zone will run alongside the already established, Laboratory, Cleanroom, Ingredients, Processing and Machinery, and the Buildings Facility zones.

Register to attend for free below.